rosiglitazone has been researched along with Animal Mammary Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, L; Doran, A; Faraji, F; Goldberger, N; Ha, NH; Hu, Y; Hunter, KW; Keane, T; Lee, MP; Shukla, A; Yang, HH | 1 |
| Bojkova, B; Garajova, M; Kajo, K; Kassayova, M; Kiskova, T; Korpova, M; Kubatka, P; Miklosova, M; Orendas, P; Pec, M | 1 |
| Clinton, SK; Rosol, TJ; Vanbuskirk, AM; Yee, LD; Young, DC | 1 |
3 other study(ies) available for rosiglitazone and Animal Mammary Carcinoma
| Article | Year |
|---|---|
An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes.
Topics: Animals; Cell Adhesion Molecules; Cell Line, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome-Wide Association Study; Kruppel-Like Transcription Factors; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred NZB; Mice, Transgenic; Nectins; Promyelocytic Leukemia Zinc Finger Protein; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones | 2016 |
Rosiglitazone shows partial oncostatic effect in rat mammary carcinogenesis.
Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Female; Glycemic Index; Hypoglycemic Agents; Insulin; Mammary Neoplasms, Animal; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2013 |
Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
Topics: Animals; Cell Line, Tumor; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Hypoglycemic Agents; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Plant Oils; PPAR gamma; Receptor, ErbB-2; Rosiglitazone; Thiazolidinediones | 2005 |